We are always fascinated by the CNS applications of cyclodextrin, and this invention from University of Arizona – Kristian Doyle is a great example for future applications. Kristian proposes using HPBCD as an anti-inflammatory agent for stroke therapy. We cannot wait to read more about this promising application.
